Cornerstone Therapeutics, a specialty pharmaceutical company, has appointed Vincent Morgus as executive vice president (EVP), finance and chief financial officer (CFO). Morgus joins the company’s executive management team and will manage its finance function. He will report to Craig Collard, Cornerstone’s president and chief executive officer (CEO).
Morgus joins Cornerstone from Quintiles, where he has been senior vice president (SVP), corporate development since September 2003. He joined Quintiles in June 1994 and progressed through a variety of financial management positions within the Quintiles organisation, including vice president, finance of Quintiles Americas and CFO of Quintiles Informatics.
Prior to working at Quintiles, Morgus held controller positions at Q+E Software and DaVinci Systems. He started his career as an auditor for Arthur Andersen in northern California. Morgus earned his MBA from the University of North Carolina’s Kenan-Flagler Business School and his BSc from the Pennsylvania State University’s Smeal College of Business.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more